Nucleotides, nucleosides and nucleobases belong to the non-protein-nitrogen (NPN) fraction of milk. The largest amounts of ribonucleosides and ribonucleotides ± ribose forms only were considered in this review ± were measured directly after parturition in bovine milk and other ruminants as well as in the milk of humans. Generally, concentrations of most of the nucleos(t)ides tend to decrease gradually with advancing lactation period or nursing time. The species-specific pattern of these minor constituents in milk from different mammals is a remarkable property and confirms, at least, the specific physiological impact of these minor compounds in early life. The physiological capacity of these compounds in milk is given by the total potentially available nucleosides. The main dietary sources of nucleos(t)ides are nucleoproteins and nucleic acids which are converted in the course of intestinal digestion into nucleosides and nucleobases the preferred forms for absorption in the intestine. Thus, nucleosides and nucleobases are suggested to be the acting components of dietary and/or supplemented nucleic acid-related compounds in the gut. They are used by the body as exogenous trophochemical sources and can be important for optimal metabolic functions. Up to 15 % of the total daily need for a breast-fed infant was calculated to come from this dietary source. Concerning their biological role they not only act as metabolites but are also involved as bioactive substances in the regulation of body functions. Dietary nucleotides affect immune modulation, e.g. they enhance antibody responses of infants as shown by a study with more than 300 full-term healthy infants. Dietary nucleos(t)ides are found to contribute to iron absorption in the gut and to influence desaturation and elongation rates in fatty acid synthesis, in particular long-chain polyunsaturated fatty acids in early stages of life. The in vitro modulation of cell proliferation and apoptosis has been described by ribonucleosides, in particular by modified components using human cell culture models. Due to the bio-and trophochemical properties of dietary nucleos(t)ides, the European Commission has allowed the use of supplementation with specific ribonucleotides in the manufacture of infant and follow-on formula. From the technochemical point of view, the ribonucleoside pattern is influenced by thermal treatment of milk. In addition ribonucleosides are useful indicators for quantifying adulterations of milk and milk products.
Introduction
Nucleotides, nucleosides and nucleobases, occurring in the sub-milligram range per litre, belong to the non-proteinnitrogen (NPN) fraction of milk. The terms nucleoside and nucleotide will consider only ribose forms in this review. Although specific compositions of milk ribonucleotides have been described for several mammalian species by different authors since the late 1950s (Manson, 1956; Johke & Goto, 1962; Larson, 1976; Gil & Sanchez-Medina, 1981a,b) and although their role as dietary modulators is of current interest concerning the supplementation of infant formula with individual ribonucleotides Commission Directive, 1996) , it was only during the last decade that the ribonucleosides have become an object of food research (Tiemeyer et al. 1984; Schlimme et al. 1986 Schlimme et al. , 1991 Schlimme et al. , 1997b Raezke et al. 1988; Raezke & Schlimme, 1990; Groû et al. 1992; Schneehagen & Schlimme, 1992; Topp et al. 1993; Schlimme & Schneehagen, 1995) . The species-specific concentration pattern of the milk constituents shows the species-specific physiological relevance of these minor compounds for the neonate. It is generally taken for granted that these species-specific concentration patterns are physiologically relevant as otherwise the evolutional process would have resulted in elimination of the species-specific pattern of this substance group.
Compositional aspects

Ribonucleosides
A reported study on the concentration levels and pattern of ribonucleosides in raw bovine milk throughout a lactation period under defined feeding conditions has shown that, with the exception of the colostral phase, the levels of these minor milk constituents vary only slightly (Raezke & Schlimme, 1990; Schlimme et al. 1991) . From all measured values for a given ribonucleoside it appears that the nucleoside concentration decreases during the colostral phase and reaches a constant level approximately three weeks postpartum (Table 1) . In comparison to Gil & Sanchez-Medina's (1981a,b) findings on nucleotides in bovine milk, no distinct maximum concentration of the nucleosides was observed during the first two days after parturition (Raezke & Schlimme, 1990; Schlimme et al. 1991) .
In the colostral phase the ribonucleoside contents in milk exceeded markedly the mean content established throughout lactation (Table 1) . In contrast to the unmodified ribonucleosides, the modified components m1Ado and t6Ado showed this pronounced dependence on lactation only in the first week of lactation. The rather high ribonucleoside concentrations ± particularly of uridine ± in colostral milk provokes questions about the lactobiochemical causes of this finding. It remains to be clarified, for example, whether the origin of milk ribonucleoside is humoral and/or local. In the first case, ribonucleosides penetrate from blood into milk via the blood±milk barrier (Ziv & Sulman, 1975; Larson et al. 1980; Ziv & Heavner, 1984) ; in the second case they result from metabolic processes in the mammary gland and are excreted from the lactating cell into the alveolar lumen or formed by postsecretory metabolic processes in milk. Thus the high metabolic activity of the mammary gland should be considered along with the increased transfer rate of the ribonucleosides circulating in the blood through the blood± milk barrier in the first days postpartum. During this period the colostrum contains a high proportion of blood constituents (Larson et al. 1980) . Postsecretory metabolic processes attributable to milk enzymes (e.g. alkaline phosphatase, adenosine deaminase), somatic cells, and micro-organisms are markedly pronounced in colostral milk Martin et al. 1997) . Tiemeyer et al. (1984) have reported uridine and cytidine concentrations, respectively, five and two times larger than those summarized in Table 1 . These anomalies may be explained by differences in the methods used. The method (Tiemeyer et al. 1984) involves an elaborate and manually performed sample pretreatment, which may allow enough time for postsecretory conversions to occur Martin et al. 1997) .
On examining the results for mature bovine milk, it is striking that the concentrations of the pyrimidine ribonucleosides are about 17 mmol/l, i.e. approximately fivefold greater than those of the purine ribonucleosides (about 3 mmol/l). This reflects, among other things, the lactobiochemical importance of uracil ribonucleotides, e.g. UDPhexoses for lactose biosynthesis in the mammary gland. The results of ribonucleoside analyses in bovine milk at different stages of lactation, including the colostrum phase, agree with findings by Gil & Sanchez-Medina (1981a,b) of rather large contents ± up to 0´3 mmol/l ± of UDP-glucose and UDP-galactose, mainly during the colostral phase. Therefore, the previously observed (Raezke & Schlimme, 1990; Schlimme et al. 1991) tenfold increased concentration of uridine (about 0´1 mmol/l) during the first week of lactation (Table 1) is not surprising.
In contrast to bovine milk, the concentrations of the pyrimidine and the purine ribonucleosides are almost equal in goat milk . The concentration of purine nucleosides (17 mmol/l) in goat milk is fivefold greater than in bovine milk. These results correlate with those described for the nucleotide contents of goat and bovine milk (Gil & Sanchez-Medina, 1981a,b) .
The composition of ribonucleosides in human milk differs from that found in the milk of ruminants not only quantitatively but also qualitatively (Groû et al. 1992; Schneehagen & Schlimme, 1992; Topp et al. 1993; Schlimme & Schneehagen, 1995; Schlimme et al. 1996a Schlimme et al. , 1997b . Interindividual mean values of eight ribonucleosides quantified during mature stages of lactation are given in Table 2 . The concentration profiles of the nucleosides Raezke & Schlimme (1990) , details with respect to the automated operation of the ribonucleoside analyzer are described elsewhere (Raezke & Schlimme, 1990; Schlimme et al. 1991) . Each mean value is the arithmetic mean of determinations (in duplicate) in the first (a), second (b) and third (c) lactation week postpartum as well as throughout the whole lactation period with the exception of the first 3 weeks postpartum (d). (Schlimme & Schneehagen, 1995) .
Ribonucleotides
Common ribonucleotide contents in cow's milk at different stages of lactation have been measured after isolation by ion-exchange chromatography followed by postcolumn enzymic characterization of pooled chromatographic fractions (Gil & Sanchez-Medina, 1981a) . (Gil & Sanchez-Medina, 1981a) . A few hours after parturition (2 h) a very low content of ribonucleotides was found, whereas after about 1 day postpartum (27 h) the ribonucleotide contents reached a maximum which decreased gradually as lactation continued (Gil & Sanchez-Medina, 1981a,b) . This pattern is also valid with regard to the total amount of ribonucleotides, i.e. including ribonucleoside-5 H -mono-, di-and triphosphates (SA t , SC t , SG t , SU t ) as well as UDPgalactose and -glucose (Gil & Sanchez-Medina, 1981b) . At two days postpartum the following concentration levels (mmol/l) have been described: SA t 67´8Y SC t 60´5Y SG t 36´5Y SU t 1495´0Y UDP-galactose 320´2Y UDPglucose 362´3X Orotic acid is the main nucleotide-related compound in bovine milk, its concentration increases with advancing lactation by about one order of magnitude and reaches a level of about 400 mmol/l 6 months after parturition (Gil & Sanchez-Medina, 1981b) .
The concentration of common ribonucleotides is about one to two orders of magnitude higher than that of common ribonucleosides (Gil & Sanchez-Medina, 1981a; Raezke & Schlimme, 1990; Schlimme et al. 1991) . 5 H -AMP and 5 H -CMP have been found to be present in all milk samples from colostral to mature stages of lactation, whereas 5 H -UMP has not been detected later than 3 weeks post partum. 5
H -GMP has been reported to be practically absent from bovine milk. The results reported by Gil & SanchezMedina (1981a) agree with former findings described, e.g. by Johke & Goto (1962) .
Nucleotides were isolated from human milk for the first time in the early 1960s (Deutsch & Nilsson, 1960; Kobata, 1963) . Widely fluctuating concentrations of ribonucleotides (4±70 mg/l corresponding to 10±200 mmol/l) have been reported from subsequent studies (Deutsch & Nilsson, 1960; Kobata, 1963; Gil & Sanchez-Medina, 1982; Janas & Picciano, 1982) , in part at least dependent on different analytical procedures used for quantification. Gil & Sanchez-Medina (1982) give concentration data found for ribonucleotides at different stages of lactation in human milk (Table 4) . Most of the data show that cytosine and uracil nucleotides comprise the largest fractions of the nucleotide content. These findings agree well with the ribonucleoside pattern ( Table 2) . Gil & Sanchez-Medina (1982) report on contents of UDP-galactose and -glucose which are about 10 mmol/l for both UDP-sugars and vary only slightly throughout lactation. All in all, the total ribonucleotide content is higher in human than in ruminant milk (Molina et al. 1996) . Orotic acid is present in the milk of ruminants but not in human milk.
Although nucleoside and nucleotide analyses have been performed for years, there are only a small number of studies that have collected quantitative data about all the nucleot(s)ide sources, as there are nucleoproteins, nucleic acids and nucleot(s)ide derivatives, including coenzymes, which can all contribute to the nucleot(s)ide content in body fluids. Leach et al. (1995) have defined the nucleoside content, analytically accessible via the aforementioned approaches, as the`total potentially available nucleosides' TPAN (Table 5 ). The mean contents of individual nucleosides in colostrum, transitory and mature human milk from 100 women in childbed from Europe (Germany, France, Italy) were taken into account at establishing the mean value (Leach et al. 1995) . In the USA the mean values of the four nucleosides of eleven women in childbed were found by Leach et al. (1995) to be within the variation limit of the European proband collective.
In Table 5 , in addition to ribonucleosides and ribonucleotides, the TPAN values for human milk (Leach et al. 1995) are represented, including the contents of ribonucleot(s)ides and of oligo-and polymeric ribonucleic acids (RNA). The TPAN content, partially stemming from ribonucleic acids, was significantly different with regard to the four individual nucleosides, and reflected above all the relevance of adenine nucleotides in bioenergetics and biosynthesis. Inosine was detected in human milk in concentrations one order of magnitude smaller than that of the TPAN contents of the other four nucleosides. In most of the milk samples no inosine was found (Leach et al. (Sugawara et al. 1995) .
Based on the presented results, the quantity of nucleotides or nucleosides to be added to infant formula to obtain TPAN contents similar to those in mature human milk can be evaluated. This would allow the advantageous properties of nucleot(s)ides would be made available to non-breastfed infants via ingestion of supplemented infant formula (see below).
For a better evaluation of the concentration level of ribonucleosides in human milk (Table 2 ) the nutrient density (mg/MJ) of these minor compounds should be compared to that of certain vitamins in milk: vitamin A (239) (Souci et al. 1994) , adenosine (278), cytidine (417), nicotinamide (589) (Souci et al. 1994) .
Trophochemical aspects
Nucleotides play key roles in nearly all biochemical processes in cell metabolism and are the monomeric precursors of nucleic acids. Nucleotides are provided by either endogenous biochemical sources ± de novo synthesis and/or salvage pathway ± or by exogenous trophochemical sources, i.e. by dietary supply.
Dietary nucleotides are ingested mainly as nucleoproteins (Uauy, 1989 , Uauy et al. 1996 and are converted in the course of intestinal digestion into monomeric compounds. Nucleosides and nucleobases are translocated across the plasma membrane by specified facilitateddiffusion carriers and sodium-dependent transporters (Plagemann & Wohlheuter, 1984; Aronow et al. 1986; Bronk & Hastewell, 1987; Ullman et al. 1987; Belt & Noel, 1998; Vijayalakshmi et al. 1992; Griffith & Jarvis, 1993; Jarvis, 1996) located in intestinal and kidney epithelial cells (Le Hir & Dubach, 1985; Darnowski et al. 1987; Lee et al. 1988; Jarvis, 1989; Williams & Jarvis, 1991; Gutie Ârrez et al. 1992) . When nucleoproteins and/or nucleotides are fed, there is evidence that the gut will activate the transcription of enzymes responsible for the salvage pathway, in particular in the upper intestine. It is known that some tissues such as the intestinal mucosa and bone haematopoietic cells preferentially utilize the salvage pathway due to limited capacity for de novo synthesis (Uauy, 1989) , i.e. for these cells the exogenous supply of nucleic acid derived components can be important for optimal functions. From this view nucleotides and related compounds have been recognized to be semiessential (Uauy, 1989; Molina et al. 1996) . Uauy (1989) has calculated to what extent preformed dietary nucleotides can cover the total body need of these components. He has estimated a nucleotide pool of 9±15 g per kg body weight of a full-term newborn. Considering a daily growth rate of 10 g/kg an accretion rate of total nucleotides for a 3 kg infant would be approximately 12 mg nucleotides per g body weight gain. The ingestion of milk nucleotides for a breast-fed newborn was calculated to be less than 2 % of daily needs and up to 15 %, if dietary nucleic acids are considered (Uauy, 1989) . Uauy (1989) concluded that`nucleotides may have potential effects on gut and related tissues, which would be most important to their influence, but would not be likely to have systemic effects given the very small contribution of dietary supply to overall nucleotide economy'.
The presence of specific nucleos(t)ides in human milk may be a factor in the immune response of breast-fed infants (Gyorgy, 1971) and are suggested as growth factors for the neonate (Barness & Carver, 1996) . However, clinical studies with nucleotide supplemented formula have not shown detectable effects on weight gain, linear growth and other anthropometric indices of growth (Uauy, 1989 and cited references) .
In this context Pickering et al. (1998) investigated whether human milk and ribonucleotides added to infant formula at levels present in human milk enhance infant immunity as measured by antibody response to immunization. A total of 370 full-term healthy infants were enrolled in the study. They were divided into three groups for a period of 12 months; 311 infants (84 %) completed the study. The control group (125/107 infants, 46 % female) were given a milk-based control formula and the nucleotide group (121/101; 42 % female) the same formula fortified with 73 mg nucleotides/l. The target level of fortification was based on that of human milk (Leach et al. 1995) and was adjusted to 31´2 mg 5 H -CMP; 17´7 mg 5 H -UMP, 9´8 mg 5 H -AMP, and 14´4 mg 5 H -GMP per litre in the nucleotide formula (see Table 6 ). The third group were fed human milk (124/103; 54 % female) for 2 months and then further on exclusively human milk or Similac w -formula with iron (Ross Lab., Columbus, USA) until 12 months of age. As a parameter for the development of the infants' immune system the vaccination reaction was followed up for the first year of life. According to specifications of the American Academy of Pediatrics, the vaccinations against infections by Haemophilus influenzae, diphtheria, tetanus and oral polio virus were performed at the ages of 2, 4 and 6 months. During the sixth, seventh and twelfth months the antibody responses were determined. The Pickering et al. (1998) study closed with the following conclusion:`Infant formula fortified with nucleotides enhanced Haemophilus influenzae and diphtheria humoral antibody responses. Feeding human milk caused an enhanced antibody response to oral polio virus. ' The aforementioned study collected data on diarrhoea illness and showed that the ingestion of nucleotide-fortified formula or human milk was associated with a significant decrease in the incidence of diarrhoea when compared to the control group (Pickering et al. 1998) .
Futhermore, a series of clinical studies on adults investigated the effects of RNA supplemented enteral food in comparison with RNA-free food. These studies were primarily performed by van Buren & Rudolph (1997) and resulted in the findings that optimal patient outcome may depend on provision of dietary nucleotides during a period of stress. These data support the conclusion that dietary nucleotides are conditionally essential nutrients. In this context, a publication by Fairbairn & Litt (1922) is of interest. The paper reports on a successful subcutaneous application of Nuclein (nucleic acid) in the case of different infections showing that this compound is a valuable adjunct to other treatment of infection.
Due to the trophochemical properties of dietary nucleos(t)ides, the supplementation of infant formula and follow-on formula with nucleotides has been used for many years in some member states of the European Union as well as in third-world countries. As no negative effects related to the nucleotide supplementation are known the Commission Directive 96/4/EC (1996) allows the supplementation of infant formula with nucleotides according to concentrations given in Table 6 (Commission Directive, 1996) .
Supplementation of infant formula with nucleotides and/ or nucleosides should be allowed up to levels present in human milk. In evaluating the physiological capacity of nucleosides Leach et al. (1995) reported experimental findings concerning the TPAN including all mono-, oligoand polymeric sources available in milk for the generation of these compounds via digestion and metabolism (values are given in Table 5 ). 5 H -IMP, which was not used for nucleotide supplementation of infant formula in the Pickering et al. (1998) study, is also not mentioned in a recent recommendation Table  6 ) due to its low TPAN portion (Leach et al. 1995) .
Regarding the supplemention of infant formula with nucleotides it should be noted that the current EC Regulation (the`Life Science Research Office' of the USA is working on a corresponding regulation) takes into account only those unmodified milk nucleotides that are released from mono-, oligo-and polymers during digestion and metabolism. It has not been considered that the whole TPAN content of human milk also includes the modified nucleot(s)ides that can be released in RNA breakdown reactions. The regulative potential of modified nucleosides seems to be prospective but is mainly unexplored.
Biochemical aspects
The need for nucleosides and nucleotides for chemical processes in biological systems is met by a combination of de novo synthesis and reutilization of these compounds by the salvage pathway. Whereas some systems, such as liver cells, have highly active de novo purine and pyrimidine nucleotide synthesis, other systems, such as gut epithelial cells, have limited capacity for de novo synthesis (Uauy, 1989; Uauy et al. 1990 ). Uauy et al. (1990) demonstrated that dietary nucleosides are able to enhance gut growth and maturation of the weanling rat. In particular, the formation of mucosal protein and mucosal DNA was found to be more pronounced in the proximal segment and the villi in this gut segment to be taller in the nucleoside-fed animal group (Uauy, 1989; Uauy et al. 1990) . Furthermore, the ratio of the enzymes maltase (EC 3.2.1.20) and lactase (EC 3.2.1.23), which is an index for gut maturation, was increased in the nucleoside supplemented group (Uauy et al. 1990 ). Leleiko et al. (1979 Leleiko et al. ( , 1983 Leleiko et al. ( , 1987 have described the effect of dietary nucleosides on the activity of the enzyme hypoxanthine±guanine phosphoribosyltransferase (HGPRT) in the small intestine of rats. HGPRT is the ratelimiting enzyme in the salvage pathway of purine nucleotides (Leleiko et al. 1979 (Leleiko et al. , 1983 (Leleiko et al. , 1987 Uauy et al. 1990) . Diets free from purine nucleosides and bases lower the intestinal HGPRT activity and decrease the level of messenger RNA of this salvage pathway related key enzyme (Uauy et al. 1990) .
Mice fed ad libitum on chow plus water supplemented with nucleotides (3´5 mg/100 ml) for six weeks have been shown to exhibit increased natural killer cell (NK) activity in the spleen and lower macrophage activation compared to mice receiving chow alone (Carver et al. 1990 ). The biological effects found need further investigation to get more insight into the molecular processes induced by dietary nucleos(t)ides. From experimental findings of Barness' group (Carver et al. 1990; Barness & Carver, 1996) it is known that infants fed with a formula supplemented with nucleotides (5 H -AMP, 4 mg/l; 5 H -CMP, 20 mg/l; 5 H -GMP, 2 mg/l; 5 H -UMP, 5 mg/l; 5 H -IMP, 2 mg/ l) show (in contrast to infants fed the same formula without nucleotide supplement) an immune response (natural killer cells, interleukin-2) similar to the immunological effect in breast-fed infants. These data suggest these normal milk constituents may be physiologically important.
It has been suggested that nucleos(t)ides contribute to iron absorption in the gut (McMillan et al. 1977) . It was found that inosine increases intestinal uptake of iron in rats (Faelli & Esposito, 1970) . Thus human milk`may be a factor in facilitating iron absorption in breast-fed infants' (McMillan et al. 1977) . Dietary nucleotides may also be involved in lipid metabolism (Sanchez-Pozo et al. 1986; Sanchez-Pozo & Gil, 1996) by stimulating a-lipoprotein synthesis. Plasma levels of major lipoprotein fractions have been studied in different groups of newborn infants (e.g. preterm, full-term neonates) fed on formula with and Table 6 . Comparison of the supplemented quantity of nucleotides in infant formula according to the EC Directive, the nucleotide group (Pickering et al. 1998 ) and the supplementation recommendation * The conversion on mg nucleotide/l infant formula was calculated under the assumption that the infant formula used is isocaloric with human milk (69 kcal/100 g milk according to Souci et al. 1994) ; nucleotide values are given as disodium salt. ² Without addition of 5 H -IMP. ³ Not recommended.
without supplementation of nucleotides (Sanchez-Pozo & Gil, 1996) . From their experimental findings Sanchez-Pozo & Gil (1996) concluded that`dietary nucleotides may have a positive effect on the lipoprotein metabolism of newborns by increasing HDL synthesis'. Long-chain polyunsaturated fatty acids (LC-PUFA) such as arachidonic, eicosapentaenoic and docosahexaenoic acids are important compounds in cell membrane structure. LC-PUFA are present in adequate amounts in human milk but not in adapted cowmilk-based formula. At-term infants fed with formula have lower amounts of LC-PUFA-levels in plasma, and their concentration in red blood cell membrane phospholipids has been shown to be lower than in breast-fed infants (Putnam et al. 1982; Carlson et al. 1986 Carlson et al. , 1987 Koletzko et al. 1989; Sanchez-Medina & Gil, 1996) . After supplementation of the formula with nucleotides an increase of LC-PUFA in the plasma and red blood cells was observed DeLucchi et al. 1987; Sanchez-Medina & Gil, 1996) . Very probably these effects are related to an influence of dietary nucleotides on desaturation and elongation rates in fatty acid metabolism . The in vitro and in vivo influences of nucleos(t)ides on liver regeneration have been reported. Five kinds of nucleic acid components ± inosine, cytidine, uridine, thymidine and 5
H -GMP ± were studied in monolayer cultures of hepatocytes concerning their effects on DNA and RNA synthesis. The results reported by Ohyanogi et al. (1996) confirmed the importance of nucleos(t)ides in enhancing nucleic acid metabolism depending on each individual component and suitable concentrations.
The in vitro modulation of cell proliferation and apoptosis (for review see Martin et al. 1994 ) by individual ribonucleosides has been investigated by Meisel et al. (1998 Meisel et al. ( , 1999 using peripheral blood lymphocytes (PBL), HL-60 cells (promyelocytic leukaemia) and Caco-2 cells (colon adenocarcinoma) as human cell culture models. Modulating effects of several ribonucleosides were found in the range of 10 27 to 10 23 mol/l. The millimolar concentration was the most effective dosage of all ribonucleosides studied (Table 7) . The following ribonucleosides had a marked inhibitory effect on proliferation of PBL and HL-60 cells (Meisel et al. 1998): Ado, m1Ado, m6Ado, m6,2Ado, ip6Ado, m2,2Guo . Except for m1Ado, these ribonucleosides also induced apoptosis of HL-60 cells. A significant apoptotic effect on PBL was found with m6,2Ado and ip6Ado. It is noteworthy that the antiproliferative effect in HL-60 cells, and to some extent the enhancement of apoptosis, revealed a relationship between increasing cell reactivity and the degree of chemical modification of the adenine entity (Table 7 ) (Meisel et al. 1998) . Regarding Caco-2 cell activity, m1Ado, m6Ado, m6,2Ado, ip6Ado and Guo had a pronounced effect as stimulants of apoptosis as well as inhibitors of proliferation. m2Guo induced significant apoptosis of Caco-2 cells but proliferation remained unchanged (Table 7) . There is increasing evidence that apoptosis and necrosis represent the extreme ends of a wide range of possible morphological and biochemical deaths (Leist & Nicotera, 1997) . The two classical types of cell death can occur simultaneously in cell cultures exposed to the same stimulus. The mode of cell death induced by Ado and several modified ribonucleosides was apoptotic.
To elucidate the possible mechanisms underlying the apoptosis-inducing activities of ribonucleosides, the timedependent utilization at the extra-and intracellular level and the possibility of a receptor-mediated induction of apoptosis was recently investigated (Meisel et al. 1998) . It has been found that ribonucleosides can modulate apoptosis of HL-60 cells via different mechanisms. Ado may follow at least two different pathways in triggering apoptosis of HL-60 cells: (1) mainly through entry into cells mediated by nucleoside transporter and direct activation of as yet unidentified intracellular events; and (2) partially through activation of extracellular A 2A -like receptors. Modulation of apoptosis by ip6Ado seems to involve an as yet unidentified extracellular receptor-mediated mechanism. It is not yet clear if an A 3 receptor-mediated apoptotic pathway contributes to Ado-or ip6Ado-induced cell death.
It is worth noting that the cancer cell lines HL-60 and Caco-2 were more reactive to apoptotic stimulation than non-malignant PBL (Meisel et al. 1998) . Most anticancer drugs produce apoptosis in sensitive cells (Hickman, 1992) involving an increased apoptotic response of cancerous cells and a minimal response from normal cells. For example, micromolar concentrations of purine nucleoside analogues (2-chloro-2 H -deoxyadenosine, 9-b-D-arabinosyl-2-fluoroadenine) are reported to be effective as apoptosisinducing chemotherapeutic agents in the treatment of several types of leukaemia, and it has been shown that their mechanisms of action implicate cellular signalling networks (Robertson et al. 1993) .
Regarding the natural presence in living systems, modified ribonucleosides are mainly found in transfer Meisel et al. (1998) .
RNA and originate from cellular RNA breakdown. It is known that the pattern of these metabolic products is altered in body fluids of individuals suffering from neoplastic diseases, i.e. modified ribonucleosides serve as pathobiochemical marker molecules for cancer (Borek, 1971; Gehrke & Kuo, 1990; Schlimme et al. 1990a; Schwarzenau et al. 1990) . As a vast majority of tumour promoters are potent inhibitors of apoptosis (Wright et al. 1994) , it seems unlikely that cancer cells as such produce apoptosis-inducing ribonucleosides. It remains to be clarified if they are released by healthy cells as a reaction against malignant cells. However, this hypothesis is supported by our findings that cancer cell lines (HL-60, Caco-2) are reactive to apoptotic stimulation by modified ribonucleosides (Meisel et al. 1998) .
Food-derived inducers of apoptosis may be of significance as exogenous anticarcinogens in the control of malignant cell proliferation where the intestinal tract could be the primary target site for a possible selective apoptotic stimulant against malignant cells.
Technochemical aspects
The pattern of ribonucleosides in mature milk varies only slightly throughout lactation. From experimental findings concerning changes in the contents of ribonucleosides in heat-treated milk Schlimme et al. 1993 Schlimme et al. , 1994 Schlimme et al. , 1998 Martin et al. 1995 Martin et al. , 1997 Martin et al. , 1998 it can be concluded that the concentrations of cytidine, guanosine and inosine present in raw milk show a multifold increase in milk which has been subjected to thermization and holder pasteurization, whereas the adenosine level decreases. On the other hand, these enzyme-(e.g. adenosine deaminase, alkaline phosphatase) catalysed changes in the content of unmodified ribonucleosides in milk are not observed in milk samples after short-and longtime pasteurization, high temperature pasteurization, ultrahigh heating and sterilization. The changes in milk ribonucleoside contents found in these heating regions are mainly attributable to the catalytic activity of the milk enzymes in the course of the heating-up phase.
The level of m1Ado varies only slightly throughout lactation and was found in raw bulk milk to be 0´4 mmol/l. m6Ado, which is not detectable under the pH and temperature conditions prevailing in thermally untreated milk , is formed by a Dimrothrearrangement from m1Ado as a function of heating time and temperature Schlimme et al. 1993 Schlimme et al. , 1994 Martin et al. 1995) . This rearrangement follows first order kinetics in the temperature range between 1158C and 1508C with a z-value of 26´88C and a Q 10 -value of 2´36 (Schlimme et al. 1994; Martin et al. 1997) . The kinetic data found for this rearrangement agree quite well with those found for other thermally induced chemical reactions in milk, e.g. lactulose formation or thiamine loss.
It can be concluded from the viewpoint of dairy technology that these minor constituents are useful as chemical indicators to quantify adulterations of milk and milk products, e.g. thermal milk treatment and ± not reviewed in this paper ± to distinguish differently processed products, e.g. butter types (Schlimme et al. 1990b (Schlimme et al. , 1996b (Schlimme et al. , 1997a Meisel et al. 1997) .
Conclusion
Nucleosides and nucleotides belong to the group of natural bioactive substances in milk and colostrum that show a species-specific pattern. They are used by the body as exogenous trophochemical sources. The physiological capacity of these compounds in milk is given by the total potentially available amount of nucleosides. They are not only active as metabolites but, furthermore, seem to be important in the regulation of body functions. For example, they enhance antibody responses, contribute to iron absorption in the gut and influence long-chain polyunsaturated fatty acid synthesis in early life. Recent findings on effector properties in human cell model systems imply that modified nucleosides, in particular, inhibit cell proliferation and activate apoptosis. Owing to these biochemical properties of nucleosides and nucleotides, the European Commission allows the supplementation of infant and follow-on formula. Thus, the positive effects of breast milk are also made available to neonates that are not breastfed. Further studies are required to evaluate these findings on the regulative potential of milk nucleos(t)ides and of dietary nucleos(t)ides in general especially in the early stages of life.
